282 related articles for article (PubMed ID: 16869345)
21. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Rostom A; Moayyedi P; Hunt R;
Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
Lanas A
Postgrad Med; 2005 Jun; 117(6):23-8, 31. PubMed ID: 16001765
[TBL] [Abstract][Full Text] [Related]
24. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
Leung Ki EL; Chan FK
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
[TBL] [Abstract][Full Text] [Related]
25. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Nardulli G; Lanas A
Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
[TBL] [Abstract][Full Text] [Related]
26. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
27. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.
Peura DA
Am J Med; 2004 Sep; 117 Suppl 5A():63S-71S. PubMed ID: 15478855
[TBL] [Abstract][Full Text] [Related]
28. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
[TBL] [Abstract][Full Text] [Related]
29. [Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
Shim YK; Kim N
Korean J Gastroenterol; 2016 Jun; 67(6):300-12. PubMed ID: 27312830
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
31. NSAIDs-induced gastrointestinal damage. Review.
Arroyo M; Lanas A
Minerva Gastroenterol Dietol; 2006 Sep; 52(3):249-59. PubMed ID: 16971869
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Lanas A
Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
[TBL] [Abstract][Full Text] [Related]
33. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.
Becker JC; Domschke W; Pohle T
Br J Clin Pharmacol; 2004 Dec; 58(6):587-600. PubMed ID: 15563357
[TBL] [Abstract][Full Text] [Related]
34. [Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
Chaussade S; Abitbol V
Presse Med; 2003 Nov; 32(37 Pt 2):S60-3. PubMed ID: 14763358
[TBL] [Abstract][Full Text] [Related]
35. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs.
Peng S; Duggan A
Expert Opin Drug Saf; 2005 Mar; 4(2):157-69. PubMed ID: 15794710
[TBL] [Abstract][Full Text] [Related]
37. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
38. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
39. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
Chan FK
Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
[TBL] [Abstract][Full Text] [Related]
40. Understanding NSAID-PPI-COX-2 interrelationships.
Singh G
Drugs Today (Barc); 2004 Mar; 40 Suppl A():21-4. PubMed ID: 15190384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]